CBIO
Crescent Biopharma
CBIO
CBIO
43 hedge funds and large institutions have $104M invested in Crescent Biopharma in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
43
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.79M | |
| 2 | +$2.26M | |
| 3 | +$163K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$54.8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$42.4K |
Top Sellers
| 1 | -$173K | |
| 2 | -$117K | |
| 3 | -$105K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$92K |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$88K |